Passage BIO Files Annual Report
Ticker: PASG · Form: ARS · Filed: 2026-04-07T07:02:54-04:00
Sentiment: neutral
Topics: annual-report, sec-filing, biotechnology
TL;DR
Passage BIO filed its 2025 ARS on 4/7/26. Check it for financials.
AI Summary
Passage BIO, Inc. filed its Annual Report to Security Holders (ARS) on April 7, 2026, for the period ending December 31, 2025. The report details the company's financial and operational status for the fiscal year. Passage BIO, Inc. is a biotechnology company focused on biological products.
Why It Matters
This filing provides shareholders and potential investors with a comprehensive overview of Passage BIO's performance and financial health for the fiscal year 2025.
Risk Assessment
Risk Level: low — This is a routine annual filing providing historical information, not indicating new risks.
Key Players & Entities
- Passage BIO, Inc. (company) — Filer
- 0001787297 (company) — CIK
- 2026-04-07 (date) — Filing Date
- 2025-12-31 (date) — Period of Report
FAQ
What is the CIK number for Passage BIO, Inc.?
The CIK number for Passage BIO, Inc. is 0001787297.
When was the ARS filing accepted by the SEC?
The ARS filing was accepted by the SEC on April 7, 2026.
What period does this Annual Report to Security Holders cover?
This report covers the period ending December 31, 2025.
What is the business address of Passage BIO, Inc.?
The business address is ONE COMMERCE SQUARE, 2005 MARKET STREET, 39TH FLOOR, PHILADELPHIA PA 19103.
What SIC code is associated with Passage BIO, Inc.?
The SIC code is 2836 for Biological Products, (No Diagnostic Substances).
From the Filing
EDGAR Filing Documents for 0001104659-26-040132 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form ARS - Annual Report to Security Holders: SEC Accession No. 0001104659-26-040132 Filing Date 2026-04-07 Accepted 2026-04-07 07:02:54 Documents 1 Period of Report 2025-12-31 Effectiveness Date 2026-04-07 Document Format Files Seq Description Document Type Size 1 ARS pasg-20251231xars.pdf ARS 19084702 Complete submission text file 0001104659-26-040132.txt 26288010 Mailing Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103 Business Address ONE COMMERCE SQUARE 2005 MARKET STREET, 39TH FLOOR PHILADELPHIA PA 19103 2678660312 Passage BIO, Inc. (Filer) CIK : 0001787297 (see all company filings) EIN. : 822729751 | State of Incorp.: DE | Fiscal Year End: 1231 Type: ARS | Act: 34 | File No.: 001-39231 | Film No.: 26842890 SIC : 2836 Biological Products, (No Diagnostic Substances) (CF Office: 03 Life Sciences)